Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been
Filed Against Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA)
OKLAHOMA CITY, OK -- (Marketwired) -- 06/26/13 -- On June 24, 2013,
a class action lawsuit was filed in the United States District Court
for the District of Columbia against Vanda Pharmaceuticals, Inc.
(NASDAQ: VNDA). The complaint alleges violations of federal
securities laws, Sections 10(b) and 20(a) of the Securities Exchange
Act of 1934 and Rule 10b-5, including allegations of issuing a series
of material or false misrepresentations to the market which had the
effect of artificially inflating the market price during the Class
Period, which is December 18, 2012 through June 18, 2013.
Plaintiff seeks to recover damages on behalf of all Vanda
Pharmaceuticals, Inc. shareholders who purchased common stock during
the Class Period and are therefore a member of the Class as described
above. You may move the Court no later than Monday, August 26, 2013
to serve as a lead plaintiff for the entire Class. However, in order
to do so, you must meet certain legal requirements pursuant to the
Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and
participate in this or any other securities litigation, or should you
have any questions or concerns regarding this notice or preservation
of your rights, please contact:
K. Lynn Nunn
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: firstname.lastname@example.org
Or, visit the firm's website at www.federmanlaw.com
Press spacebar to pause and continue. Press esc to stop.